Natural terpenoids have elaborate structures and various bioactivities, making difficult their synthesis and labeling with isotopes. We report here the enzymatic total synthesis of plant hormone gibberellins (GAs) with recombinant biosynthetic enzymes from stable isotopelabeled acetate. Mevalonate (MVA) is a key intermediate for the terpenoid biosynthetic pathway.
13 C-MVA was synthesized from 13 C-acetate via acetyl-CoA, using four enzymes or fermentation with a MVA-secreted yeast. The diterpene hydrocarbon, ent-kaurene, was synthesized from 13 C-acetate and 13 C-MVA with ten and six recombinant enzymes in one test tube, respectively. Four recombinant enzymes, P450 monooxygenases and soluble dioxygenases involved in the GA 4 biosynthesis from ent-kaurene via GA 12 were prepared in yeast and Escherichia coli. All intermediates and the final product GA 4 were uniformly labeled with 13 C without dilution by natural abundance when [U-13 C 2 ] acetate was used. The 13 C-NMR and MS data for [U- 13 C 20 ] ent-kaurene confirmed 13 C-13 C coupling, and no dilution with the 12 C atom was observed.
Key words: biosynthesis; 13 C-NMR; isotope; recombinant enzyme; terpenoid Terpenoids are widely distributed in nature, and over 25,000 compounds have been reported from mammals, plants and microorganisms. 1) Natural terpenoids function as hormones in animals, plants and insects, drug materials such as paclitaxel, artemisinine and cotylenin/ fusicoccin, and cell components such as cholesterol. Bioactive natural terpenoids that are only available in small amounts in plants or microorganisms are targets for total and combinatorial chemical syntheses. [2] [3] [4] [5] However, the chemical synthesis of terpenoids requires stereochemical control and involves structures with extensive functional groups.
All terpenoids are biosynthesized from dimethylallyl diphosphate (DMAPP) and isopentenyl diphosphate (IPP), both of which are derived from mevalonate (MVA) or 2C-methyl-D-erythritol 4-phosphate (MEP) pathway.
6) The MVA pathway involves phosphorylation to MVA, and subsequent decarboxylation leads to IPP. Isomerization and a carbon chain elongation reaction afford the biosynthesis of several prenyl diphosphates. MVA itself is biosynthesized from acetyl-CoA via acetoacetyl-CoA and hydroxymethylglutaryl-CoA (HMG-CoA). At least seven enzymes are involved in the biosynthesis of IPP from acetate (Fig. 1A) . The structural variation of terpenoids depends on the chain length of prenyl diphosphates, the cyclic structure generated by cyclases, and oxidative modification to the carbon skeleton. If terpenoid biosynthesis could be manipulated at the enzyme level, the synthesis of many kinds of compound with complicated and precise structures should be achievable.
We attempted the total enzymatic synthesis of gibberellin A 4 (GA 4 ) as a model experiment to accomplish this objective, because all the genes involved in GA 4 biosynthesis have been identified and characterized in both plants and fungi. 7) GA 4 biosynthesis in higher plants mainly comprises three phases depending on characterization of the biosynthetic enzymes and cellular compartment in higher plants: step 1, geranylgeranyl diphosphate (GGDP) synthesis and a cyclization reaction for ent-kaurene biosynthesis; step 2, oxidation mediated by two cytochrome P450 monooxygenases; and step 3, synthesis of an active GA by two 2-oxoglutarate-dependent dioxygenases (Fig. 1B) .
Step 1 determines the carbon chain length of prenyl diphosphate as a diterpene (C 20 ) and involves several enzymes. A lot of ent-kaurene synthases have been reported from some organisms, including higher plants, GA-producing fungi 8) and bryophytes. 9,10) Two synthetic enzymes, ent-coparyl diphosphate synthase and ent-kaurene synthase, are involved in the biosynthesis of ent-kaurene in higher plants, whereas the bifunctional enzyme, CPS/KS, synthesizes ent-kaurene from GGDP in GA-producing fungi and bryophytes. Steps 2 and 3 involve some differences among higher plants and GA-producing fungi. The ent-kaurene oxidase (KO) genes in higher plants and GA-producing fungi belong to the CYP701A family and CYP503 family, respectively, even though these enzymes catalyze the same reaction. 8, 11) In addition, the synthesis of GA 4 from GA 12 is mediated by 2-oxoglutarete-dependent dioxygenases in higher plants, but the same reaction is mediated by cyctochrome P450 monooxygenases in GAproducing fungi.
To undertake the synthesis of GA 4 by using biosynthetic enzymes, fourteen recombinant enzymes have to be prepared by heterologous expression in Escherichia coli and yeast. We have already conducted the in vitro functional analysis of all GA biosynthetic recombinant enzymes in higher plants, as well as of bifunctional entkaurene synthases in mosses and fungi. [9] [10] [11] [12] [13] [14] [15] We recently succeeded in the recombinant protein production and functional analysis of both KO (CYP701A) and entkaurenoic acid oxidase (KAO, CYP88A) from lettuce and rice by heterologously expressing their genes in the yeast, Pichia pastoris. 16, 17) We describe here the enzymatic total synthesis of bioactive GA 4 from acetate. The enzymes responsible for the MVA pathway were selected for the enzymatic synthesis, because the starting materials were easily obtained. All the genes for the biosynthesis of GA 4 from acetate via acetyl-CoA, MVA, GGDP, and ent-kaurene were expressed in E. coli and Pichia to produce recombinant enzymes. Then, we established an in vitro synthesis of uniformly 13 Clabeled GA 4 from starting materials of [U-13 C 2 ] acetate and [U-13 C 6 ] MVA by our system of using the recombinant enzyme mix.
Materials and Methods
Chemicals. ent-Kaurene was extracted from the leaves of Cryptomeria japonica and purified by SiO 2 column chromatography as previously described.
18) The following cofactors were used: ATP (Wako, Osaka, Japan), NADPH (Nacalai Tesque, Kyoto, Japan), and Coenzyme A (Sigma Aldrich, MO, USA Cloning of open reading frames for the recombinant biosynthetic enzymes. The source of the biosynthetic enzyme genes responsible for the MVA pathway was Neurospora crassa. This fungus was cultured in a liquid medium (0.5% yeast extract, 0.5% KH 2 PO 4 , 0.2% MgSO 4 and 0.1% CH 3 COONH 4 ) for 4 d at 28 C on a reciprocal shaker (140 rpm). The mycelia were filtered and frozen in liquid nitrogen. The frozen mycelia were ground to a fine powder in liquid nitrogen, and then total RNA was extracted by using the EASY Prep RNA reagent (Takara Bio, Shiga, Japan) according to the manufacturer's protocol. PolyA þ RNA isolation and double-stranded cDNA synthesis were performed as previously reported.
12) The Arabidopsis cDNA library previously reported was used. 19) Eight ORFs (acetyl-CoA synthase, ACS; acetoacetyl-CoA thiolase, AACT; HMG-CoA synthase, HMGS; HMG-CoA reductase, HMGR; mevalonate kinase, MVK; phosphomevalonate kinase, PMVK; diphosphomevalonate decarboxylase, DMDC; and IPP isomerase, IPI) which were necessary for generating the biosynthetic enzymes from acetate to DMAPP, were amplified from an N. crassa cDNA library by PCR. A bacterial GGDP synthase (GGPS) gene, which encoded an enzyme converting DMAPP/IPP to GGDP, was cloned from Sulfolobus acidocaldarius.
20) The plasmid containing SaGGPS was used as the PCR template. The CYP701A gene encoding KO cloned from Pisum sativum was supplied by Dr. S. M. Swain.
21) The CYP88A gene encoding KAO from Lactuca sativa was the same as that A B Fig. 1 . In Vitro Synthetic Route to GGDP and GA Dependent on the MVA Pathway and Biosynthesis of GAs in Plants.
Panel A shows the biosynthetic route from an acetate to GGDP via the MVA pathway. Nine enzymes were responsible for the biosynthesis of GGDP. The synthesis of one molecule of IPP consumed six molecules of ATP and two molecules of NADPH. Panel B shows the GA 4 biosynthetic pathways in plants and in the enzyme cocktail. ent-Kaurene, the common precursor of GA, was synthesized via the MEP pathway and MVA pathway in plants and the enzyme cocktail, respectively. Both KO and KAO in microsomes in the enzyme cocktail produced synchronously in Pichia yeast were used for preparing the GA 12 synthetic cocktail. Both 20ox 3 and 3ox 1 were added to the GA 12 synthetic cocktail after determining the GA 12 synthesis. previously used. 16) These P450 genes were amplified from the plasmid containing each ORF. Two ORFs of the GA biosynthetic genes, GA20-oxidase 3 (20ox 3; Q39112) and GA3-oxidase 1 (3ox 1; Q39103), were cloned from the A. thaliana cDNA library. The polymerase chain reaction (PCR) was performed by using an Advantage-HF 2 PCR kit (Clontech, CA, USA), based on the manufacturer's protocol. The fourteen sets of primers used for amplification are listed in Supplemental Table S1 ; see Biosci. Biotechnol. Biochem. Web site. All PCR products were ligated into the pCR2.1 vector (Invitrogen) to confirm their DNA sequences by using the ABI PRISMÔ 3130xl Genetic Analyzer (Applied Biosystems, CA, USA).
Construction of the protein expression vectors. Nine ORFs for the enzymatic synthesis from acetate to GGDP were introduced into the multi-cloning site of the pQE-30 vector (Qiagen, Hilden, Germany). The ORF of bifunctional ent-kaurene synthase (CPS/KS) cloned from the liverwort, Jungermannia subulata, was introduced into the pCold vector (Takara Bio). 9) Two GA oxidase ORFs, 20ox 3 and 3ox 1, were introduced into the pMALc2 vector (NEB, MA, USA) to produce fusion forms of maltose-binding protein (MBP). 14) Two P450 ORFs, KO and KAO, were introduced into the multicloning site of pPICZ-A (Invitrogen, CA, USA) in tandem to synchronously produce two P450 proteins in one host cell. The whole KAO ORF was first introduced into the pPICZ-ÁPmeI vector in which the PmeI site in the promoter region had been deleted. This KAO expression cassette containing the AOX promoter and terminal region in the pPICZÁPmeI vector was then amplified by PCR and introduced downstream of the pPICZ-KO terminal region. The pPICZ-KO/KAO tandem vector was finally propagated in E. coli and linearized with PmeI for transformation.
Expression and production of soluble recombinant biosynthetic enzymes. Twelve enzymes (ACS, AACT, HMGS, HMGR, MVK, PMVK, DMDC, IPI, GGPS, CPS/KS, 20ox 3 and 3ox 1) that had been obtained from the soluble fraction were produced in E. coli grown in a 2 Â YT medium (800 mL) containing ampicillin (100 mg mL À1 ) at 37 C for 3 h. Induction of the recombinant protein was initiated by adding IPTG (final concentration of 1 mM) when the OD 600 value had reached 0.6. After an additional 20 h of incubation at 18 C, the cells were collected, washed with a 50 mM Tris-HCl buffer (pH 7.5) and resuspended in 5 mL/g fresh weight of a lysis buffer (100 mM TrisHCl at pH 7.5, 10% glycerol, and 0.5 mM EDTA). The cells were then treated with lysozyme and sonicated to obtain a soluble protein after centrifuging at 9,000 rpm for 30 min. The His-tagged recombinant enzymes were purified by Ni-NTA affinity column chromatography according to the manufacturer's protocol. Both the recombinant 20ox 3 and 3ox 1 proteins fused with MBP were used for enzymatic synthesis without purification.
Preparation of the membrane-binding protein by using the Pichia expression system. KO and KAO proteins were produced in Pichia yeast basically according to the details in our previous report. 19) After MeOH induction, the cells were retrieved by centrifugation, disrupted by glass beads, and removed from the crude enzyme solution. A microsomal fraction was prepared by centrifugation using PEG4000 and resuspended in a reaction buffer (100 mM Tris-HCl at pH 7.5, 10% glycerol, and 0.5 mM EDTA) for use in the enzymatic synthesis reaction.
[U-13 C 6 ]MVA production by Saccharomycopsis fibuligera fermentation. The yeast, S. fibuligera, was incubated at 26 C for 6 d in 50 mL of a medium containing 0.5% polypeptone, 0.25% yeast extract, 0.1% KH 2 PO 4 , 0.05% MgSO 4 , 0.1% CaCO 3 and 10% [U-13 C 6 ] D-glucose. The resulting culture filtrate was extracted three times with 2-butanone at pH 2.0. This crude extract was purified in an SiO 2 column (silica gel 60, Merck, NJ, USA) and eluted with n-hexane/EtOAc (1:1 28 C, the reaction mixture was acidified by adding HCl and left for 30 min at room temperature to convert MVA to the lactone form. The acidified sample was extracted three times with EtOAc and concentrated in a gentle stream of dry N 2 gas. The concentrated sample was loaded into an SiO 2 cartridge column (Varian, CA, USA) that had previously been washed with 3 mL of EtOAc and equilibrated with n-hexane/EtOAc (1:1, v/v). The mevalonolactone was eluted with 10 mL of n-hexane/ EtOAc (1:9, v/v) which was evaporated to dryness with a gentle stream of dry N 2 gas at room temperature.
Synthesis of ent-kaurene from acetate and MVA. The MVA substrate was added to an ent-kaurene synthetic cocktail which contained six recombinant enzymes (15 mg of MVK, 310 mg of PMVK, 20 mg of DMDC, 150 mg of IPI, 20 mg of GGPS, and 60 mg of CPS/KS), 5 mM MgCl 2 , and 10 mM ATP. An additional four enzymes for synthesizing MVA were mixed into the ent-kaurene synthetic cocktail as already described when acetate was used as the starting material. The prepared cocktail was incubated at 28 C for 8 h, and then the product was extracted three times with cyclohexane and concentrated with dry N 2 gas.
Synthesis of GA 4 from ent-kaurene. A GA 12 synthetic cocktail was prepared by suspending two P450 enzymes in the reaction buffer. entKaurene was incubated with this GA 12 synthetic cocktail in the presence of 5 mM NADPH. After 2 h of incubation at 28 C, the GA 4 synthesis was performed for 2 h at 28 C after adding two enzymes (20ox 3 and 3ox 1) and cofactors (5 mM ascorbate, 5 mM -ketoglutarate and 0.5 mM FeSO 4 ). The product was extracted with EtOAc and analyzed by GC-MS after derivatization.
GC-MS and NMR analyses. The sample was analyzed by the JEOL (Tokyo, Japan) JMS-Bu25 GC-MS system (ionization energy of 70 eV, and filament current of 300 mA) coupled with a DB-5 capillary column (0.25 mm in diameter, 15 m long, and 0.25 mm in film thickness; J&W Scientific, Folson, CA, USA). The oven temperature program for entkaurene and GAs has been described in previous reports. 10, 14) The samples were derivatized to the methyl ester and methyl ester trimethylsilyl ether by using diazomethane and diazomethane/Nmethyl-N-trimethylsilyl-trifluoroacetamide (MSTFA, Thermo Fisher Scientific, MA, USA) for the identification of GA 12 and GA 4 , respectively. The 13 C-NMR (150 MHz) spectra were recorded at room temperature with a JEOL JNM-A600 FT-NMR system in CDCl 3 , the solvent signals being used as the references.
Results
Preparation of the basic enzyme cocktail for synthesizing GGDP from acetate
We initially prepared a basic enzyme cocktail for the in vitro synthesis of GGDP, a common precursor of diterpenoids. Nine recombinant enzymes responsible for the conversion steps from an acetate to GGDP (Fig. 1A) were prepared as components of the enzyme cocktail. The eight ORFs (Fig. 1A) for biosynthetic enzymes from the acetate to DMAPP were cloned and amplified by PCR from a N. crassa cDNA library. Among these, HMGR is an integral membrane binding proteins to the endoplasmic reticulum, although the others are soluble proteins. It has been reported that the membranespanning domain near the N-terminal region of HMGR was not necessary for the enzyme activity. 23) Hence, N. crassa HMGR in soluble protein form (the residual 510 amino acids near the C-terminal, ÁHMGR) was produced in E. coli by truncating the N-terminal region (Á2-664). The resulting eight ORFs and the bacterial GGPS gene amplified by PCR were introduced into the pQE-30 vector. All recombinant proteins were produced in E. coli as His-tagged fusion proteins and purified by Ni-NTA resin ( Fig. 2A and B) . The DDBJ accession number of each cDNA is listed in Supplemental Table S1 .
The basic enzyme cocktail in this context indicates a mixed enzyme solution containing recombinant enzymes and cofactors in one test tube for synthesizing prenyl diphosphates. We first carried out the in vitro synthesis of GGDP from MVA by using an enzyme cocktail containing five recombinant enzymes (MVK, PMVK, DMDC, IPI, and GGPS), Mg 2þ , and ATP. Uniformly 13 C-labeled MVA was used as the substrate to determine the enzyme products by GC-MS and 13 C-NMR. The substrate [U-13 C 6 ] MVA (97% 13 C-labeled), which was easily obtained from [U-13 C 6 ] glucose by fermentation with S. fibuligera, 24) was added to the basic cocktail, and the mixture was incubated at 28 C for 8 h. The GGDP synthesized was dephosphorylated with alkaline phosphatase and analyzed by GC-MS. The spectrum showed that the molecular and fragment ion peaks were shifted relative to the weight of the 13 C isotope, even though the retention time by GC was the same as that of the natural form (Fig. 3) . The yield of GGDP was estimated as 27% from the results of the GC-MS analysis.
Although we could obtain [U-13 C 6 ] MVA by the fermentation method just described, this procedure carried the risk of dilution of the isotope-labeled molecules. Therefore, MVA was enzymatically synthesized from a labeled acetate to avoid this problem. Four recombinant enzymes (ACS, AACT, HMGS and ÁHMGR), CoA, ATP and Mg 2þ were utilized for an in vitro synthesis of MVA. [U-13 C 2 ] sodium acetate (99.8%
13 C-labeled) was incubated in the MVA synthetic cocktail at 28 C for 8 h, and MVA was obtained. The GC-MS and 13 C-NMR data for mevalonolactone were the same as those for fermentated [U-13 C 6 ] mevalonolactone. The yield of MVA from the acetate was estimated to be about 54% (0.7 mg).
Synthesis of [U-
13 C 20 ] ent-kaurene by using a specific enzyme cocktail ent-Kaurene is a crucial hydrocarbon intermediate in GA synthesis, and is biosynthesized by a two-step cyclization reaction with GGDP. The enzymatic synthesis of GGDP from an acetate via MVA has been described in the previous section. We used a bifunctional ent-kaurene synthase from the liverwort, J. subulata (JsCPS/KS), to efficiently convert GGDP into ent-kaurene in vitro, and prepared recombinant JsCPS/ KS (Fig. 2B ).
9)
The enzyme cocktail specific to ent-kaurene synthesis was prepared by adding JsCPS/KS to the GGDP basic enzyme cocktail using [U-13 C 6 ] MVA. After incubating the reaction mixture, ent-kaurene was trapped in cyclohexane overlayed on the aqueous phase in a test tube and then extracted again with cyclohexane. Fig. 5 . The carbon atoms completely labeled with the 13 C isotope gave high-intensity peaks and carbon-carbon coupling in the 13 C-NMR analysis. Enzymatic synthesis of GA 12 with CYP701A and CYP88A
The oxidation of ent-kaurene and ent-kaurenoic acid on the GA biosynthetic pathway of higher plants is catalyzed by two distinct P450 monooxygenases, KO and KAO, that produce ent-kaurenoic acid and GA 12 , respectively (Fig. 1B) . It was found that recombinant CYP701A and CYP88A catalyzed the respective steps. Our previous report has demonstrated that both P450 genes were heterologously expressed in a Pichia yeast system, and a functional analysis was performed in vitro.
16,17,19) Both CYP701A (pea) and CYP88A (lettuce)
genes in the present work were synchronously expressed in the Pichia transformant, and the microsome was used for synthesizing GA 12 from ent-kaurene. These two genes were inserted in tandem with the pPICZ vector and transformed into Pichia which already had a P450 reductase gene in the AOX promoter region. 19) The transformant by two-step selection, using distinct concentrations of zeocin (0.1 mg/mL and 1.0 mg/mL) was incubated to induce both the CYP701A and CYP88A genes by adding MeOH. The microsomal fraction prepared by centrifugation was incubated with [U-13 C 20 ] ent-kaurene in a test tube at 28 C for 2 h. The products were extracted with EtOAc and analyzed by GC-MS, after their derivatization with diazomethane. The mass chromatogram monitored at m=z 348 and 319 detected the [U-13 C 20 ] GA 12 methyl ester at 9.18 min by GC. The full-scan mass spectrum indicated that all carbon atoms of the GA 12 methyl ester were substituted by the 13 C isotope without any natural abundance ( Fig. 4C and D, Table 1 ). The yeast microsomal fraction containing the CYP701A and CYP88A enzymes converted ent-kaurene to GA 12 . Such synthetic intermediates as ent-kaurenoic acid and 7-hydroxy-entkaurenoic acid were not detected by GC-MS. It was impossible to synthesize GA 12 from MVA or acetate in one step when these P450 enzymes were added to the ent-kaurene synthetic enzyme cocktail.
Enzymatic synthesis of GA 4 from acetate The biosynthetic conversion of GA 12 and GA 9 into GA 9 and GA 4 was catalyzed by 20ox and 3ox, respectively (Fig. 1B) . Although fungal cyctochrome P450 monooxygenases also catalyzed the same reactions, two dioxygenases were selected as components of the enzyme cocktail. Both oxidases are 2-oxoglutaratedependent dioxygenases and require 2-oxoglutarate, ascorbate, and Fe 2þ . Among the numerous 20ox and 3ox enzymes which have been cloned from higher plants and functionally characterized, we selected Arabidopsis 20ox 3 and 3ox 1 for the enzymatic synthesis of GA 4 from GA 12 . These 20ox 3 and 3ox 1 enzymes converted GA 12 to GA 9 and GA 9 to GA 4 , respectively, and minimally accumulated intermediates and shunt product such as GA 25 . 25) These recombinant enzymes were produced in E. coli in the MBP fusion form 13) and used for the enzymatic synthesis without purification (Fig. 2C) .
As described above, we used two enzyme cocktails which separately synthesized ent-kaurene from acetate and GA 12 from ent-kaurene. After confirming the GA 12 synthesis by GC-MS, the 20ox 3 and 3ox 1 enzymes were added to the residual reaction mixture in the same test tube and incubated at 28 C for 2 h. The EtOAc extract from the enzyme reaction mixture was derivatized by MSTFA and diazomethane. Figure 4E and F show the result of the GC-MS analysis of the product, the [U- 13 C 19 ] GA 4 methyl ester trimethylsilyl ether. A comparison with the authentic GA 4 methyl ester trimethylsilyl ether showed the retention time of both derivatives by GC to be the same, while the molecular ion peak and fragmentation ion peaks of the [U-13 C 19 ] GA 4 methyl ester trimethylsilyl ether were both shifted according to the number of 13 C atoms. The total yield of GA 4 from the acetate was estimated to be 0.15%. 
Discussion
The goal of an enzymatic total synthesis of bioactive GA 4 from acetate was achieved by successful production of recombinant proteins and adjustment of reaction conditions. All the recombinant enzymes involved in the synthesis of GA 4 from acetate were prepared by a heterologous expression system using E. coli and yeast (Fig. 2) . These fourteen enzymes for GA 4 synthesis included soluble enzymes and membrane-bound P450s. The soluble enzymes were produced in E. coli in the His-tagged and MBP fusion forms. The appropriate combination of the expression constructs and host cells was critical for mass production of the recombinant enzymes. We have previously established the heterologous production of recombinant P450 enzymes for plant hormone biosynthesis. 16, 17, 19) Two independent P450 enzymes were synchronously produced in a single transformant of Pichia yeast in this present work. This procedure involved the efficient preparation of an enzyme cocktail for GA 12 synthesis rather than having to prepare two microsomal fractions separately containing KO and KAO enzymes. Such synchronous expression of multiple P450 products has been reported by using human CYP1A1, CYP2B6 and CYP2C19 in planta. 26) These three independent P450s were active in in vivo experiments, whereas the reactions catalyzed by our P450s (CYP701A3 and CYP88A) operated in vitro by using the microsomal fraction prepared from Pichia cells.
Cell-free systems have been used for several decades in numerous biosynthetic studies and for the in vivo synthesis of such natural products as biosynthetic intermediates. GA biosynthetic studies have used cellfree systems prepared from immature seeds of plants for GA biosynthesis and for the preparation of radioisotopelabeled biosynthetic intermediates. [27] [28] [29] However, natural materials may often be difficult to prepare in a cellfree extract on a large scale. In addition, it is difficult to standardize cell-free systems because the quality and characteristics of enzyme extracts are not consistent with separate preparations from intact materials or organisms. Furthermore, the enzyme reactions and processes in a cell-free system cannot be regulated; for example, a natural-based cell-free system cannot selectively accumulate biosynthetic intermediates. 30, 31) Recombinant enzyme-based cocktails are powerful tools to solve these problems in the synthesis of natural products. If farnesyl diphosphate is necessary to study sesquiterpene biosynthesis, farnesyl diphosphate synthase is used instead of GGPS in the cocktail. The substitution of farnesyl diphosphate synthase and amorphadiene synthase for GGPS and JsCPS/KS in the enzyme cocktail successfully produced amorphadiene (Supplemental Fig. S1A ). Another example is taxadiene, a diterpene hydrocarbon, which could be synthesized when taxadiene synthase was added to the cocktail instead of JsCPS/KS (Supplemental Fig. S1C ). Diverse structural platforms of terpenoids are also determined by terpene cyclases in nature; for example, rice has several diterpene cyclase genes in the genome. 32) Each cyclase plays a role in strictly determining the structures of GA and phytoalexins. Our enzyme cocktail thus has the ability to generate multiple synthetic reactions for various terpenoids in a natural biosynthetic manner. Since the GA biosynthetic genes in this work were cloned from several plant and fungal materials, 7) the total synthesis of bioactive GA 4 from an acetate could be achieved by using only recombinant enzymes, cofactors and substrates. There are two procedures for synthesizing GA 4 from GA 12 by applying enzymes: using dioxygenases from plants and using P450s from fungi. We used here dioxygenases for the GA 4 synthesis, because preparing a synthetic cocktail with various types of enzyme will be applicable to the enzymatic synthesis of other terpenoids.
Our enzymatic total synthesis system could also provide fully isotopic labeled terpenoids. We have demonstrated the synthesis of fully 13 C-labeled GA 4 and its intermediates without dilution of natural abundance. The 13 C-NMR and EI-MS data for [U-13 C 20 ] entkaurene indicated 13 C-enrichiment in which ent-kaurene was not diluted with 12 C during the enzyme reaction (Figs. 4A and 5). The enzymatic synthesis from entkaurene to GA 12 and GA 4 also proceeded without dilution. Experimental techniques using 13 C-enrichment and high-resolution NMR have been performed in metabolic studies carried out on living cells and organs of mammals. [33] [34] [35] For example, studies on the last two steps of the MEP pathway have demonstrated that the metabolism of 13 C-enriched substrates and direct 13 C-NMR measurement of the cell lysate revealed the products from enzyme reactions. 36, 37) This approach also provides a new strategy to determine the function of unknown biosynthetic genes. The methods presented here will enable the enzymatic total synthesis of other terpenoids and uniform labeling of stable isotopes. Our strategy provides a new insight into the biosynthesis and metabolomics of terpenoids.
